| the changing prevalence of cervical human papilloma virus infection. | in order to determine the change in frequency of human papillomavirus infection (hpv) over a 10-year period, cervical smears from 1978 were retrieved, cytologically reviewed and compared with cervical smears taken in 1988. in this way, the slides were reviewed using the same diagnostic criteria. the prevalence of hpv infection in the population assessed at flinders medical centre, rose from 0.58% to 5.6% over this period. | 1990 | 1964552 |
| australian women's needs and preferences for information about human papillomavirus in cervical screening. | the role of human papillomavirus (hpv) in cervical cancer and developments in medical technology to prevent cervical cancer has changed information needs for women participating in cervical screening. | 2005 | 16156944 |
| hypersensitivity reactions to human papillomavirus vaccine in australian schoolgirls: retrospective cohort study. | to describe the outcomes of clinical evaluation, skin testing, and vaccine challenge in adolescent schoolgirls with suspected hypersensitivity to the quadrivalent human papillomavirus vaccine introduced in australian schools in 2007. | 2008 | 19050332 |
| interim estimates of human papillomavirus vaccination coverage in the school-based program in australia. | in november 2006, the australian government announced the national hpv vaccination program, consisting of a course of prophylactic human papillomavirus (hpv) vaccine for all australian females aged 12-26 years. females aged 12-18 years are vaccinated through school-based programs. the school-based component commenced in april 2007, with the school years targeted varying across jurisdictions. each jurisdiction maintains comprehensive records of hpv doses delivered in the school-based programs alt ... | 2008 | 19374275 |
| challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in south australia. | to describe the process and challenges in the roll out of a large cervical cancer vaccination program to protect against human papilloma virus (hpv) infection. | 2009 | 19689598 |
| human papillomavirus dna detected in peripheral blood samples from healthy australian male blood donors. | recent studies have shown that human papillomavirus (hpv) dna can be found in circulating blood, including peripheral blood mononuclear cells (pbmcs), sera, plasma, and arterial cord blood. in light of these findings, dna extracted from pbmcs from healthy blood donors were examined in order to determine how common hpv dna is in blood of healthy individuals. blood samples were collected from 180 healthy male blood donors (18-76 years old) through the australian red cross blood services. genomic d ... | 2009 | 19697401 |
| what can surveillance of genital warts tell us? | in this review, we describe the recent epidemiology of genital warts and postulate what the future may hold as a result of the introduction of the quadrivalent human papillomavirus (hpv) vaccine. hpv types 6 or 11 are responsible for most cases and they develop in about two-thirds of women a few months after hpv 6 or 11 infections are first detected by polymerase chain reaction. surveillance data, cohort studies and cross-sectional surveys suggest that the annual incidence of genital warts excee ... | 2010 | 20719222 |
| catching up with the catch-up: hpv vaccination coverage data for australian women aged 18-26 years from the national hpv vaccination program register. | this report describes human papillomavirus (hpv) vaccine coverage data for australian women 18-26 years of age, as notified to the national human papillomavirus vaccination program register. a cross-sectional analysis was conducted of notifications to the register of hpv vaccine doses delivered as part of the national hpv vaccination program, which provided free catch-up vaccination to women 18-26 years of age across australia between 2007 and 2009. hpv vaccination coverage estimates were calcul ... | 2011 | 22010515 |
| immunisation coverage, 2012. | this, the 6th annual immunisation coverage report, documents trends during 2012 for a range of standard measures derived from australian childhood immunisation register (acir) data, and national human papillomavirus (hpv) vaccination program register data. these include coverage at standard age milestones and for individual vaccines included on the national immunisation program (nip) and coverage in adolescents and adults. the proportion of australian children 'fully vaccinated' at 12, 24 and 60 ... | 2014 | 25391407 |
| immunisation coverage annual report, 2011. | this, the 5th annual immunisation coverage report, documents trends during 2011 for a range of standard measures derived from australian childhood immunisation register data, and national human papillomavirus (hpv) vaccination program register data. the proportion of children 'fully vaccinated' at 12, 24 and 60 months of age was 91.4%, 92.2% and 89.5% respectively. although pneumococcal vaccine had similar coverage at 12 months to other vaccines, coverage was lower for rotavirus at 12 months (83 ... | 2013 | 24882234 |